Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aggrenox in SARS-CoV-2 infection
NCT04410328Phase 3Completed
- Sponsor
- Rutgers University
- Start
- Oct 2020
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dipyridamole in coronavirus disease 2019 (COVID-19), sponsored by Rutgers University. Started Oct 2020; status: completed.
02
Drugs
dipyridamole
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04410328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04410328.